Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Heilongjiang Harbin Beima Technology Development is a China-based company referenced publicly through its strategic cooperation with Shineco in industrial hemp-related research, production, and sales. Available disclosures indicate the company has been involved in developing hemp-derived cosmeceutical, pharmaceutical, and healthcare products, including CBD mask beauty products and CBD-related food products. Publicly accessible information on the company is limited, and it does not appear to have a well-documented conventional drug-development pipeline. Based on the available evidence, the company is better characterized as a commercial-stage hemp and health products business rather than a clinical-stage biotechnology developer. The firm appears to operate in the broader health and wellness segment with a focus on industrial hemp applications in China.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Heilongjiang Harbin Beima Technology Development.